To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Primary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo in girls and women with Rett syndrome Key Secondary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo on ability to communicate in girls and women with Rett syndrome
Epistemonikos ID: 6dba6af843da719c31727c37ef9a4efe5763ac90
First added on: Mar 01, 2025